Nisoli E, Tonello C, Benarese M, Carruba M O
Department of Pharmacology, Medical Toxicology and Chemotherapy, School of Medicine, University of Milan.
J Neurochem. 1995 Oct;65(4):1580-7. doi: 10.1046/j.1471-4159.1995.65041580.x.
SR 58611A, a selective agonist of gut and brown adipose tissue beta 3-adrenoceptors (beta 3 ARs), has been reported to have antidepressant-like activity in rodents, by indicating brain beta 3ARs as the sites of this property. SR 58611A and its acid metabolite SR 58878A, as opposed to BRL 37344, ICI 215,001, and CGP 12177, increased cyclic AMP levels in rat frontal cortex. ICI 215,001, differently from BRL 37344, at concentrations in the millimolar range antagonized norepinephrine- or (-)-isoproterenol-stimulated adenylyl cyclase partially. The increase of cyclic AMP levels induced by SR 58878A was blocked selectively by beta 1AR antagonist CGP 20712A but not by beta 2AR antagonist ICI 118,551. In addition, PCR analysis did not reveal beta 3AR mRNA, and no specific beta 3AR binding sites were detected by [3H]CGP 12177 in rat frontal cortex. When down-regulation of the beta 1AR ligand binding and mRNA levels had been induced in frontal cortex by chronic administration of imipramine, SR 58878A as well as norepinephrine and (-)-isoproterenol inceased the cyclic AMP production less markedly. Our findings indicate that beta 3ARs are absent in the adult rat frontal cortex, and that various beta 3AR agonists differently affect the frontal cortex beta 1ARs, indicating that SR 58611A may exert its putative antidepressant effect acting on the frontal cortex beta 1ARS.
SR 58611A是肠道和棕色脂肪组织β3 -肾上腺素能受体(β3ARs)的选择性激动剂,据报道在啮齿动物中具有抗抑郁样活性,表明脑β3ARs是该特性的作用位点。与BRL 37344、ICI 215,001和CGP 12177不同,SR 58611A及其酸性代谢物SR 58878A可提高大鼠额叶皮质中的环磷酸腺苷(cAMP)水平。与BRL 37344不同,ICI 215,001在毫摩尔浓度下可部分拮抗去甲肾上腺素或(-)-异丙肾上腺素刺激的腺苷酸环化酶。SR 58878A诱导的cAMP水平升高被β1AR拮抗剂CGP 20712A选择性阻断,但未被β2AR拮抗剂ICI 118,551阻断。此外,聚合酶链反应(PCR)分析未显示β3AR mRNA,且在大鼠额叶皮质中未通过[3H]CGP 12177检测到特异性β3AR结合位点。当通过长期给予丙咪嗪诱导额叶皮质中β1AR配体结合和mRNA水平下调时,SR 58878A以及去甲肾上腺素和(-)-异丙肾上腺素对cAMP产生的增加作用明显减弱。我们的研究结果表明,成年大鼠额叶皮质中不存在β3ARs,并且各种β3AR激动剂对额叶皮质β1ARs的影响不同,这表明SR 58611A可能通过作用于额叶皮质β1ARs发挥其假定的抗抑郁作用。